Why I remain bullish on Energy Transfer: strong EBITDA and cash flow growth, 6.7% yield, upside catalysts, and key risks ...
AstraZeneca ranked fifth on TIME Magazine’s 2026 World’s Best Companies list - its highest position to date and the top ranking among pharmaceutical companies - based on sustainability transparency, ...
TARRYTOWN, N.Y., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial results for the third quarter of 2026 and provided a business update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results